NEW YORK – Swift Biosciences and Arbor Biosciences, a division of Chiral Technologies, have partnered to offer a complete workflow for RNA-seq library preparation and targeted enrichment of the SARS-CoV-2 genome.
The new workflow, designed for epidemiological research and public health surveillance, combines Swift's patented Adaptase technology and RNA library kits with Arbor's myBaits technology for hybridization-based target enrichment of the virus for whole-genome sequencing.